Searching for the Genetic Determinants of Peripheral Arterial Disease: A Review of the Literature and Future Directions.


Journal

Cardiology in review
ISSN: 1538-4683
Titre abrégé: Cardiol Rev
Pays: United States
ID NLM: 9304686

Informations de publication

Date de publication:
Historique:
entrez: 5 4 2019
pubmed: 5 4 2019
medline: 19 6 2019
Statut: ppublish

Résumé

Peripheral arterial disease (PAD) is a significant but under-recognized disease that is poorly understood despite population-scale genetic studies. To address this morbid disease, clinicians need additional tools to identify, prevent, and treat patients at risk for PAD. Genetic studies of coronary artery disease have yielded promising results for clinical application, which have thus far been lacking in PAD. In this article, we review recent findings, discuss limitations, and propose future directions of genomic study and clinical application. However, despite many studies, we still lack definitive genetic markers for PAD. This can be attributed to the heterogeneity of PAD's pathogenesis and clinical manifestations, as well as inconsistencies in study methodologies, limitations of current genetic assessment techniques, incompletely comprehended molecular pathophysiology, and confounding generalized atherosclerotic risk factors. The goals of this review are to evaluate the limitations of our current genetic knowledge of PAD and to propose approaches to expedite the identification of valuable markers of PAD.

Identifiants

pubmed: 30946061
doi: 10.1097/CRD.0000000000000231
pii: 00045415-201905000-00006
doi:

Substances chimiques

Genetic Markers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

145-152

Auteurs

Dean L Kellogg (DL)

From the Division of Cardiology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX.

Susan Fisher-Hoch (S)

Department of Epidemiology, Human Genetics & Environmental Sciences, University of Texas-Houston School of Public Health, Brownsville, TX.

Joseph B McCormick (JB)

Department of Epidemiology, Human Genetics & Environmental Sciences, University of Texas-Houston School of Public Health, Brownsville, TX.

Anand Prasad (A)

From the Division of Cardiology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH